We are live on
!
Find out more
E
Ergoteles Portfolio holdings
AUM
$68.2M
1-Year Est. Return
36.16%
This Fund
S&P 500
This Quarter
Est. Return
+7.33%
1 Year Est. Return
+36.16%
3 Year Est. Return
+76.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.36B
AUM Growth
+$1.15B
(+36%)
Cap. Flow
+$991M
Cap. Flow
% of AUM
22.7%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
1,807
New
1,048
Increased
148
Reduced
170
Closed
353
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$160M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$77.5M |
| 3 |
Linde
LIN
|
+$51M |
| 4 |
State Street SPDR S&P Metals & Mining ETF
XME
|
+$46M |
| 5 |
Newmont
NEM
|
+$44.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$66.5M |
| 2 |
ExxonMobil
XOM
|
+$54.9M |
| 3 |
Apple
AAPL
|
+$52.1M |
| 4 |
HMSY
HMS Holdings Corp.
HMSY
|
+$48.4M |
| 5 |
Oracle
ORCL
|
+$42.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.39% |
| 2 | Healthcare | 14.66% |
| 3 | Consumer Discretionary | 14.56% |
| 4 | Financials | 10.08% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
ADMA Biologics
ADMA
$1.96B
| $479K | 0.01% |
+299,500
| New | +$527K |
|
827
Alpha Pro Tech
APT
$51.3M
| $479K | 0.01% |
+55,900
| New | +$488K |
|
828
International Flavors & Fragrances
IFF
$19.6B
| $479K | 0.01% |
+3,208
| New | +$460K |
|
829
Lucid Motors
LCID
$2.52B
| $478K | 0.01% |
+1,660
| New | +$364K |
|
830
Lennox International
LII
$19.1B
| $478K | 0.01% |
+1,362
| New | +$459K |
|
|
UBFO
831
DELISTED
United Security Bancshares
UBFO
| $477K | 0.01% |
+58,400
| New | +$474K |
|
|
EXTN
832
DELISTED
Exterran Corporation
EXTN
| $477K | 0.01% |
100,200
+86,133
| +612% | +$369K |
|
833
M&T Bank
MTB
$36.3B
| $475K | 0.01% |
+3,270
| New | +$511K |
|
834
Portland General Electric
POR
$6B
| $475K | 0.01% |
10,300
-26,361
| -72% | -$1.29M |
|
835
CB Financial Services
CBFV
$182M
| $474K | 0.01% |
+21,400
| New | +$466K |
|
|
FARO
836
DELISTED
Faro Technologies
FARO
| $474K | 0.01% |
+6,100
| New | +$481K |
|
837
Quaker Houghton
KWR
$2.63B
| $474K | 0.01% |
2,000
+900
| +82% | +$215K |
|
838
Tractor Supply
TSCO
$16.5B
| $474K | 0.01% |
+12,750
| New | +$467K |
|
839
FormFactor
FORM
$7.57B
| $473K | 0.01% |
+12,969
| New | +$511K |
|
|
BCLI
840
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $472K | 0.01% |
+8,289
| New | +$443K |
|
841
Simmons First National
SFNC
$3.35B
| $472K | 0.01% |
+16,100
| New | +$481K |
|
|
SAL
842
DELISTED
Salisbury Bancorp, Inc.
SAL
| $472K | 0.01% |
+18,600
| New | +$428K |
|
843
Gyre Therapeutics
GYRE
$697M
| $470K | 0.01% |
+14,467
| New | +$496K |
|
844
Sonic Automotive
SAH
$3.25B
| $470K | 0.01% |
+10,500
| New | +$510K |
|
845
Brown & Brown
BRO
$23.5B
| $467K | 0.01% |
+8,785
| New | +$452K |
|
846
Cal-Maine
CALM
$4.17B
| $467K | 0.01% |
+12,900
| New | +$483K |
|
|
CASI
847
DELISTED
CASI Pharmaceuticals
CASI
| $466K | 0.01% |
+30,040
| New | +$505K |
|
|
CKPT
848
DELISTED
Checkpoint Therapeutics
CKPT
| $466K | 0.01% |
+15,780
| New | +$437K |
|
849
OP Bancorp
OPBK
$228M
| $465K | 0.01% |
+46,260
| New | +$484K |
|
850
C&F Financial
CFFI
$254M
| $464K | 0.01% |
+9,100
| New | +$427K |
|
Similar funds
ROC
IVMX
AM
JCG
JAMONY
FA
VCM
MCMI
Ergoteles's Q2 2021 Portfolio in Review
As of Q2 2021, Ergoteles held 1,807 positions worth $4.36B, up 36% from $3.21B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Ergoteles deployed $991M of net new capital in Q2 2021, opening 1,048 new positions and adding to 148 existing holdings. Its largest new stake was Linde: 174,841 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Walt Disney, an estimated $66.5M trimmed.
- Ergoteles's largest Q2 2021 buy was Linde: 174,841 shares worth $50.5M.
- Ergoteles added most to PRA Health Sciences, Inc. in Q2 2021, an estimated $160M increase.
- Ergoteles's biggest Q2 2021 reduction was Walt Disney, cutting an estimated $66.5M.
- Ergoteles fully exited ExxonMobil in Q2 2021, selling an estimated $54.9M.
- Ergoteles's ten largest holdings make up 15% of its $4.36B portfolio in Q2 2021.
- Ergoteles opened 1,048 new positions and closed 353 in Q2 2021.
- Ergoteles's portfolio value rose 36% quarter-over-quarter to $4.36B.
Based on Ergoteles's 13F filing for Q2 2021, filed 12 Aug 2021.